Biotechnology in animal agriculture by Seidel, George E. Jr.
BIOTECHNOLOGY IN ANIMAL AGRICULTURE
I have been asked to assess the interface of biotechnology and animal agri-
culture, paying particular attention to recent successes and failures, and to 
identify potential opportunities as well as bottlenecks to further advances. 
Some aspects of this assignment are relatively straightforward, while oth-
ers require so many qualifiers as to be of limited
_______________          value. The first problem is to define biotechnol-
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ture is biotechnology, whereas a narrow defini-
tion limited to recombinant DNA techniques 
would show only barely perceptible effects on 
production agriculture at this time. A broad 
definition of biotechnology will be used and 
items of potential interest will be emphasized. 
Defining animal agriculture is also somewhat 
arbitrary. Currently, the most important agri-
cultural species in the United States are cattle, 
swine, sheep, chickens and turkeys. Horses 
might be considered more recreational than 
agricultural. A considerable percentage of beef 
cattle operations also have a huge recreational 
component, as do those concerning other spe-
cies. Many of the opportunities to apply biotechnology are on farms 
where the majority of family income is from non-farm sources. There also 
are biotechnology applications in less common species such as buffalo,
deer, goats, ducks, geese and fish.
BRIEF SUMMARY OF THE STATUS OF ANIMAL AGRICULTURE
Currently about two percent of the labor force in the United States is em-
ployed in production agriculture, and another 20 percent of the labor force 
is involved in servicing production agriculture (e.g., fertilizer, farm equip-
ment) or transporting, processing, and marketing agricultural products. 
Roughly half of these people are in the animal agriculture sector. This
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huge enterprise is reasonably successful by most measures, e.g. providing 
abundant, healthful products at the lowest cost in the world as measured 
by percentage of median disposable family income used for food (cur-
rently 12 percent). This is all the more remarkable because of the huge 
percentage of food expenditures that go for packaging, storage, process-
ing, safety and quality control, advertising, and service in restaurants and 
related establishments.
This situation is less rosy when examined in depth; e.g., those involved 
in production agriculture have not fared well over the years (a robust mea-
sure of this is the continuing exodus of people from production agricul-
ture, particularly involving animals). The huge direct and indirect govern-
ment subsidies to address this problem have met with only marginal suc-
cess and add indirectly to the cost of food, although these costs are low 
compared to most other industrialized countries. It also must be made 
plain that improving efficiency of animal agriculture with biotechnology, 
while greatly benefitting consumers, will probably harm more farmers 
than it will help because in our economic system, those who do not adopt 
more efficient techniques cannot compete with those who do. On the 
other hand, unless American farmers become more efficient, their jobs 
will be replaced by farmers in other countries who export their produce to 
the United States.
BIOTECHNOLOGIES ARE TOOLS
Agricultural practices are continually refined and perfected. For example,
10.000. 000 dairy cows currently produce considerably more milk than
25.000. 000 did in 1945; in 1990 beef production from calves of 33,000,000 
beef cows exceeded that of 45,000,000 cows in 1975. Similar successes have 
been recorded for poultry and swine. There are huge opportunities to im-
prove this performance further, particularly with cattle, since the best 
herds produce twice the output per animal as the average herd. Continued 
improvements arise from dozens of sources, each of which only contrib-
utes modestly. An excellent example is selective breeding. Although the 
improvement with each generation is modest, it accumulates like com-
pound interest. In most cases, new biotechnologies should be thought of 
as tools to aid this process. They face stiff competition from current tools, 
which already are very effective. Any compromise of currently effective 
tools must be compensated by extraordinary benefits, or the new technol-
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ogy will not even be considered. A good example is introducing a trans-
gene for disease resistance into a breeding population of dairy cows. Un-
less the transgene is already in a high milk-producing line, the economic 
costs of lowered milk production in the initial generations would cancel 
the benefits of controlling any known disease.
RECENT BIOTECHNOLOGICAL BREAKTHROUGHS
I have constructed three lists of biotechnologies used in production ani-
mal agriculture (Tables 1-3). The first list, technologies commercialized 
before 1980 (Table 1), might be considered inappropriate for the objectives 
of this paper. Nevertheless, I present them because they are of overriding
TABLE 1 EXAMPLES OF BIOTECHNOLOGIES IN WIDESPREAD USE 
COMMERCIALIZED BEFORE 1980
Selective breeding
Nutrient requirements of animals
Feed analysis
Vaccination
Veterinary diagnostics and therapeutics 
Artificial insemination (mostly cattle and poultry) 
Crossbreeding
Regulation of reproductive cycles 
Embryo transfer
Ultrasound to measure carcass fat
importance in current animal agriculture, they illustrate the kinds of tech-
nologies that work, and some of them just came into widespread use 
around 1980, e.g., regulation of reproductive cycles and embryo transfer 
technology. It is important to recognize that most technologies are ap-
plied directly only to a minority of animals in the population. Some of 
these niches only apply to specialty markets, e.g., embryo transfer to in-
troduce new germ plasm into specific pathogen-free swine herds, while 
others filter down to the whole population, e.g., artificial insemination is 
only done with five percent of beef cattle, but over half of the bulls that 
breed beef cattle via natural service are conceived by artificial insemina-
tion or had parents conceived by artificial insemination. Some biotech-
nologies apply to every individual in the population. For example, all tur-
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keys are conceived by artificial insemination because males have so much 
breast meat that it interferes physically with natural mating.
The second list, biotechnologies commercialized in the 1980s, (Table 2) 
similarly has technologies widely applied, e.g., growth promotants for 
growing beef cattle, and those used in narrow niches, e.g., storage of bo-
vine embryos in liquid nitrogen. This latter technology resulted in an en-
tirely new commodity, frozen embryos. Many frozen embryos are im-
ported and exported; a very important fringe benefit of this approach is 
the greatly decreased danger of spreading diseases compared to importing 
live animals or semen.
TABLE 2 EXAMPLES OF BIOTECHNOLOGIES IN WIDESPREAD USE 
COMMERCIALIZED AFTER I98O
Growth promotants (other than DES) and ionophores
Use of bypass (of rumen) protein and fat
Monoclonal antibodies for diagnostics
Storage of embryos in liquid nitrogen
Ivermectin to treat parasites
Ultrasound for veterinary diagnostic purposes
Ivermectin is truly a miracle drug in terms of safety and efficacy. Al-
though this drug was developed for animals, and there is no use for it in 
people in the United States, it will be one of the most important drugs ever 
developed for human use in countries where people are regularly infected 
with certain deadly or debilitating parasites, e.g., the organism causing 
river blindness in Africa.
The third list, (Table 3) technologies just being commercialized at this 
time, will be discussed item by item. The list is headed by bovine soma-
totropin (a growth hormone), a truly marvelous product of biotechnol-
ogy produced by bacteria via recombinant DNA technology and adminis-
tered to dairy cows by injection or implant about every two weeks. This 
treatment increases milk production about 20 percent compared to con-
trols. For sound reasons, it is not administered during the first quarter of 
lactation, so the increase in milk production is closer to 10 percent over 
the lifetime of the cow. The main action of this protein hormone in lactat- 
ing cows is simple: it is a so-called partitioning agent, causing the nutri-
ents that a cow eats to go to milk production rather than carcass fat. With-
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out exogenous somatotropin milk production declines markedly in many 
cows after the first third of lactation, and many of the nutrients they eat 
end up as body fat. Somatotropin has other effects too, e.g., it stimulates 
appetite so cows eat more, thus further increasing milk production.
This product is safe, efficacious, cost-effective, and does not alter milk 
composition, yet it is one of the most controversial products ever devel-
oped. One problem is current milk surpluses; another is that it is a recom-
binant DNA product. However, it is unlikely that even a few percent of re-
combinant DNA products will be able to come close to the safety and effi-
cacy parameters of this product; it should be a great cause of concern that 
this product is perceived so negatively by so many.
At this writing there is a glut of crude oil on the world market, but think 
of the benefits of 10 percent increase in fuel efficiency of internal combus-
tion engines. There would be costs too, less employment in oil fields just as 
fewer dairy cows and dairy farmers will be needed after bovine somatotro-
pin comes into use. However, precisely these kinds of efficiency are re-
quired for the American dairy farmer to compete; also, a lower number of 
cows equates to less pollution, less grain consumption, etc.
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TABLE  3 EXAMPLES OF BIOTECHNOLOGIES BEGINNING TO BE USED 
COMMERIC ALLY IN THE EARLY 1990S
Bovine somatotropins to improve milk production
Vaccines inducing antibodies distinguishable from those due to natural infec-
tions
Cloning embryos by nuclear transplantation 
Sexing embryos
In vitro maturation of oocytes from slaughterhouse ovaries 
In vitro fertilization and culture of embryos 
Oral melatonin to control seasonal breeding in sheep and goats 
Induced twinning in cattle
The second item in Table 3 is a solution to an old problem, distinguish-
ing healthy animals with antibodies due to vaccination from animals 
making antibodies due to current infection with a contagious agent. A 
well-known example is bovine brucellosis, which causes great economic 
loss due to abortion. This organism also is a threat to people; it causes 
undulant fever, which usually cannot be treated effectively, and is very de-
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bilitating for years. The program to eradicate brucellosis in cattle has been 
extremely expensive and hindered by the above problem. However anew 
vaccine developed with recombinant DNA techniques is about to be re-
leased that elicits antibodies distinguishable from those induced by the 
brucella organism itself. A similar vaccine has been developed for pseudo-
rabies in swine.
The third item in Table 3, making exact genetic copies of outstanding 
animals by nuclear transplantation has been a dream of animal breeders 
for years. This now can be accomplished by combining serial cloning of 
embryos (e.g., transplanting nuclei from a 16-cell embryo into 16 unferti-
lized oocytes, and when they reach the 16-cell stage, repeating the process) 
and cryo-preservation of embryos so that a genetic copy in embryo form 
is available after other cloned embryos become adults. If the adults are 
outstanding, copies can be made; if not, the embryos are discarded and 
other clones propagated.This technology has other advantages: automatic 
sex selection, faithful reproduction of heterozygous transgenic animals, 
and reproduction of outstanding crossbred animals. Note that without 
this technology these latter two types of animals do not breed true, much 
like the situation with hybrid corn.
Item four is sexing embryos. Although still a bit clumsy, commercial 
sexing of bovine embryos with a Y-chromosome-specific DNA probe is 
now offered commercially. This technology eventually will be replaced by 
sexed semen. The fifth item in Table 3, in vitro maturation of oocytes from 
slaughterhouse ovaries, is now becoming sufficiently reliable so that we 
can exploit this source of genetic material via in vitro fertilization and em-
bryo transfer. Because costs per animal for embryo transfer remain high, 
most applications will be in cattle for the next decade (a superior calf is 
worth much more than a superior lamb). Two properties of harvesting fe-
male gametes in this way are noteworthy. The first is reproduction from a 
dead animal. Thus a valuable cow or horse that dies or is slaughtered due 
to terminal illness can reproduce; note that this procedure works at any 
stage of the reproductive cycle and even during pregnancy. Another ad-
vantage is to exploit genes of slaughtered females with especially good car-
casses such as high dressing percentage, tender meat with minimal fat, etc.
The second noteworthy property of embryos produced in this way is 
that they can be produced in huge quantities at low cost. This makes them
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appropriate for applications such as twinning cattle, and for other bio-
technologies like cloning by nuclear transplantation. This also makes 
them ideal for many experimental purposes. A special fringe benefit is that 
experiments can be done without using experimental animals, just nearly 
worthless ovaries from commercially slaughtered cows plus frozen semen.
In vitro fertilization and culture of embryos are required to exploit 
many applications of in vitro oocyte maturation, but there are some spe-
cific uses of these technologies in addition. For example, in vitro fertiliza-
tion can be used with technologies of sexing semen that produce too few 
sperm for artificial insemination but plenty for in vitro fertilization. In 
vitro fertilization also can be used for testing fertility of males, which is ex-
tremely costly and frequently inaccurate with other procedures.
The second from last item in Table 3 concerns melatonin. Sheep and 
goats are seasonal breeders, which causes great constraints in agricultural 
productivity. They normally become pregnant when days become short 
and the nights, long. The pineal gland at the base of the brain secretes me-
latonin when it is dark and fails to do so in daylight; moreover, melatonin 
is a key regulator of reproductive hormones in these species. Therefore, 
one can cause the same effects as darkness by feeding melatonin. A feeding 
at 4 p.m. is the equivalent of darkness commencing at that time. After a 
few weeks of this animals resume fertile reproductive cycles and if mated, 
become pregnant, no matter what the season of the year.
The last item in Table 3, twinning in cattle, can be induced in several 
ways, including embryo transfer or injections to increase double ovula-
tions. These procedures are just becoming economically feasible because 
of combining some of the technologies just described. The main principle 
that makes twinning attractive is that about 70 percent of the nutrients 
that a beef cow eats in the course of a year go for her maintenance require-
ments, and the remaining 30 percent go to needs of pregnancy and lacta-
tion. Thus for 30 percent more feed, one can produce two calves instead of 
one. There is, however, higher morbidity and mortality with twins, and 
more labor is required.
PROMISING BIOTECHNOLOGIES NOT YET COMMERCIALIZED
In addition to standard recombinant DNA procedures, there are numer-
ous extremely powerful biotechnologies being used in the laboratory that
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will eventually impact on animal agriculture. A somewhat arbitrary list is 
in Table 4. A few of these items will be discussed further. The first, trans-
genic procedures, is covered in more detail elsewhere in these proceed-
ings. I want to emphasize that although transgenesis is one of the most 
powerful technologies available for scientific endeavors, it is not likely to 
have much impact in production agriculture over the next decade. By far 
the main problem is that we know so little about gene function for pro-
duction traits in farm animals that we simply do not know what genes to 
manipulate, much less how to manipulate them. This clearly will change 
eventually, and although there may be several spectacular applications be-
fore the year 2000, most will occur after that date. Other problems with 
transgenic technology include expense and the extremely long time-frame 
involved with species with long generation intervals. Sexing semen is an-
TABLE 4 EXAMPLES OF FINDINGS OR BIOTECHNOLOGIES THAT LIKELY WILL 
HAVE APPLICATION IN PRODUCTION AGRICULTURE IN THE FUTURE
Transgenic procedures 
Polymerase chain reaction 
Sexing semen 
Embryonic stem cells 
Homologous recombination 
Artificial chromosomes
Somatotropin and beta agonists for meat production
Growth factors
Second messenger systems
Transcription factors and other regulators of gene expression 
Early pregnancy factor 
Trophoblast-specific interferons 
Marker-assisted selection
other promising biotechnology. At least one method of sexing semen, 
that of using a flow cytometer, has been convincingly demonstrated to 
sort X and Y chromosome-bearing sperm of several species with 80-90 
percent accuracy. While the sperm are damaged somewhat, and the proce-
dure is much too slow to be used for routine artificial insemination, the 
sperm are reasonably fertile and could be used for in vitro fertilization. 
There is a huge and immediate market for sexed semen in cattle.
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GROWTH FACTORS, TRANSCRIPTION FACTORS, AND 
SECOND MESSENGER SYSTEMS
These fall into the category of important areas of research concerning reg-
ulation of cellular function; thousands of research papers are published in 
these areas annually, and the resulting information will be exceedingly 
useful in getting cells to do useful things. A decade from now, some of 
these will reach the interface with production agriculture with very im-
portant consequences. However, much more information is needed to 
make educated guesses concerning exactly which factors will be matched 
with which applications.
Extolling the virtues of marker-assisted selection is currently very much 
in fashion. Related procedures using restriction fragment length polymor-
phisms (RFLP) form much of the basis for projects on mapping (not se-
quencing) human and other genomes. Similar procedures have been suc-
cessfully applied to finding genes responsible for several human diseases. 
An example of how this concept works is that one tries to match up spe-
cific and easily measured genetic differences (e.g., a particular RFLP) with 
a desirable characteristic (e.g., a high percentage of unsaturated fat in 
meat) so as to quickly and easily identify the genetically superior animals 
in the population. A fringe benefit is that one can further exploit such 
matchups to locate and identify the genes responsible for the desired char-
acteristic.
This important biotechnology has many potential uses. Unfortunately, 
there are also severe limitations because dozens of genes are responsible 
for most traits of interest (e.g., fertility, growth rate, disease resistance), 
which frequently results in confusion with this approach. However, in 
other instances, especially where single genes with multiple alleles have 
huge effects, this approach is excellent.
BIOTECHNOLOGY NEEDS IN ANIMAL AGRICULTURE
If one asked about biotechnological needs, one likely would get quite dif-
ferent answers from different groups, e.g., farmers vs animal scientists. I 
have listed some of the more obvious ones in Table 5. Many of these have 
been alluded to earlier; the usefulness of most is obvious. A number of 
those listed would result in markets in excess of $100,000,000 annually. 
Some would lead to entirely new approaches and greatly increase effi-
ciency, e.g., cloning animals from adult cells.
New biotech-
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Gene maps
Basic information about all aspects of animal biology, especially appetite, stress, 
disease
Sexed semen (eggs for poultry)
Improved techniques to cryopreserve poultry semen 
Cloning animals from adult cells 
Reliable and simple transgenic technology 
Early pregnancy tests 
In vitro gametogenesis
Methods of modifying animal products for fat and other characteristics 
Quality control for salmonella, etc.
Very inexpensive diagnostics for on-farm use
Immunocastration
Reprogramming laying hens
BOTTLENECKS TO APPLYING BIOTECHNOLOGY TO 
ANIMAL AGRICULTURE
Some obvious bottlenecks are listed in Table 6. Interestingly, they fall into 
two broad categories: biological constraints and sociological/societal con-
straints. Farm animals are much more complex than single cell organisms. 
All of these organisms are more complicated than super computers or 
space ships. Therefore it takes enormous resources to understand and ma-
nipulate them to useful ends, including modifying organisms geneti-
cally. However, there is considerable optimism in scientific circles in deal-
ing with this obstacle. It is considered challenging, interesting, and impor-
tant, and progress is being made. The complexity of cells and organisms is 
truly amazing. Even non-cellular entities such as viruses are complex, and 
their interaction with cells especially complex. A graphic example is the 
human immunodeficiency (AIDS) virus; direct and indirect funding to 
understand this virus is approaching one billion dollars annually on a 
world-wide basis, and while information is accumulating exponentially, 
many questions remain concerning effective means of controlling this vi-
rus other than by human behavioral modifications. Note also that one bil-
lion dollars is really minuscule compared to military expenditures.
The other items in Table 6 are also bottlenecks, some of them diffuse 
ones. Any one or two of these might be dealt with easily, but their cumula-
tive effect can be devastating. For example, fewer students are undertaking
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TABLE 6 BOTTLENECKS TO APPLYING BIOTECHNOLOGY TO ANIMAL AGRICULTURE
Complexity of organisms 
Diffuse, underfunded efforts 
Instability of funding
Secrecy due to proprietary considerations with many sources of funding 
Research climate that discourages young scientists 
Costs of FDA approval process 
Regulatory costs of doing research
Time required to prepare proposals, get committee approvals, prepare progress 
reports, etc.
Narrow training and experience of most life scientists 
Lack of clear goals
Remoteness of many scientists from needs of farmers
graduate studies in animal biology than in the past, which perhaps is de-
sirable since employment opportunities are limited. Another very inter-
esting phenomenon is the change from predominantly men to predomi-
nantly women graduate students in these areas. It appears that fewer 
young men find this area of endeavor attractive in the United States, at 
least in part due to some of the items in Table 6.
Despite the cumulative insidiousness of the items in Table 6, many are 
desirable and necessary, and most alternatives to them are even less desir-
able. Thus, the solution is to deal with the items in Table 6, even though 
this takes huge amounts of time and funding.
SUMMARY
Hundreds of biotechnologies are applied daily in animal agriculture in the 
United States. New biotechnologies as well as new applications of older 
biotechnologies continue to be applied to increase the efficiency of animal 
agriculture. At the same time, new and more varied animal products are 
being produced. Because there are considerable time lags between con-
ceiving a new application and its use in production agriculture, it is too 
early to evaluate eventual impacts of newer technologies such as recombi-
nant DNA procedures. However, it is likely that they will be exceedingly 
important for animal agriculture in the decades ahead. Although there are 
considerable regulatory and safety costs in applying biotechnology, by and 
large, these costs are reasonable and need to be taken into account in plan-
ning and budgeting.
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